ConductScience.org, home

Trial · NCT05084599

Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section

NCT05084599, Phase 4, Completed, Peking University People's Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section. Trials, record NCT05084599. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05084599

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section
NCT number
NCT05084599
Status
Completed
Phases
Phase 4
Enrollment
124 participants, actual
Lead sponsor
Peking University People's Hospital
Conditions
Cesarean Section Complications
Interventions
Metaraminol 2.7μg/kg/min, Metaraminol 2μg/kg/min
First posted
2021-10-20
Last updated
2024-02-01

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryUmbilical artery blood pH30 seconds after deliverypH value of fetal umbilical artery blood
SecondaryhypotensionIntraoperativeNumber of Participants with systolic blood pressure reduction \>20% baseline value or systolic blood pressure \<90 mm Hg before delivery
SecondarybradycardiaIntraoperativeNumber of Participants with heart rate was ≤50 bpm before delivery Number of Participants with heart rate was ≤50 bpm before delivery Number of Participants with heart rate was ≤50 bpm before delivery
SecondaryThe incidence of nausea in pregnant womenIntraoperativeAnesthesiologist observes combined patient dictation.
SecondaryUmbilical artery blood base excess30sec after deliverybase excess of fetal umbilical artery blood
SecondaryThe incidence of vomiting in pregnant womenIntraoperativeAnesthesiologist observes combined patient dictation

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05084599

GET https://conductscience.org/api/trials/v1/NCT05084599/registered